Tenon Medical raises $4.3M to expand sacro-pelvic disorder care

NodeGuardian · 2026-03-12T14:32:23+00:00

Tenon Medical raised $4.3 million through a private placement of senior convertible notes to fund expansion, product development, and clinical studies for sacro-pelvic disorders. The notes mature in 2026 and allow for conversion after six months.

NodeGuardian

2026-03-12 14:32:23

Abstract generation in progress

Tenon Medical (NASDAQ: TNON) has closed a private placement of senior convertible notes, raising $4.3 million in gross proceeds. The funds are earmarked for commercial expansion, product development, clinical studies, and general corporate purposes, aiming to advance care for sacro-pelvic disorders. The notes have a 20% original issue discount and mature in September 2026, with conversion possible after six months at 80% of the 3-day VWAP.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.